Brian Mulnix Email and Phone Number
Brian Mulnix work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Brian Mulnix personal email
Brian Mulnix phone numbers
As the General Manager Biologics, my focus is bringing together exceptional colleagues in launching the biologic business unit at Dr Reddys Laboratories in North America. My passion is creating go-to-market commercial strategies for launches in Immunology, Oncology and Rare Disease. Over my career, I’ve had the privilege in leading teams across business development, marketing, new product strategy, analytics and commercial excellence. Key professional accomplishments:>At Pfizer, led the global Enbrel® franchise to become the world’s most successful prescription medicine. >At Leo Pharma, led the US launch of Adbry®, a prescription biologic medication for Atopic Dermatitis. Delivered on all launch metrics and patient initiatives. >Designed and implemented the US commercial model for Dr Reddys Biologics. Led the organization into biosimilars and biologic therapies.>Delivered multiple product in-licensing and business development deals across various therapeutic categories and companies. Personal experience in the rare disease space including genetic kidney disease, organ transplantation, and other rare conditions. Open to board of director roles in Biotech, Pharma and Healthcare.
-
General Manager, Biologics North AmericaDr. Reddy'S Laboratories Aug 2023 - PresentHyderabad, Ts, InCommercial head responsible for building the go-to-market commercial organization across Market Access, Marketing, Commercial Strategy, Analytics and Sales.• Designed and built the commercial organization for US market.• Championed licensing for a rare disease biologic therapy in ALS.• Led creation of launch plans for portfolio of biosimilar products in Rheumatology, Oncology and Ophthalmology.
-
Vp, Business Development & New Product StrategyLeo Pharma Oct 2022 - Aug 2023Ballerup, Dk, DkBusiness development head responsible for commercial strategy, asset in-licensing and product acquisition. Led identification and acquisition of Timber Pharmaceuticals, a Rare Disease Dermatology company. -
Vp, Us MarketingLeo Pharma Aug 2017 - Oct 2022Ballerup, Dk, DkLed the US launch of Adbry®, a biologic for atopic dermatitis, inclusive of designing the organizational footprint,launch strategy and execution and management of P&L. Directly led 20+ professionals and indirectly anorganization of 200+.• Led the go-to-market strategy and successful launch of Adbry® including organizational design, market brand positioning, FDA labeling negotiations, and lifecycle strategy.• Chaired the US Adbry® cross-functional launch team and represented US interest with global teams.• Rebuilt the US Marketing and Advocacy team with deep expertise in HCP & Med Ed marketing, Consumer & Digital strategy, and Opinion Leader & Stakeholder Advocacy relations.
-
Vp, Commercial Strategy & Business DevelopmentSun Pharma Apr 2016 - Aug 2017Mumbai, Maharastra, InCommercial head responsible for managing the Dermatology pipeline portfolio, leading in-licensing and business development evaluations, and managing the commercial analytics department within Sun Dermatology.• Led commercial evaluation for 60+ in-licensing and business development opportunitiesresulting in two major in-licensing deals (Osteoarthritis, Basal Cell Carcinoma)• Led global launch planning efforts for Ilumya® including signing a European partnership with Almirall -
Vp, Us MarketingGalderma Apr 2015 - Apr 2016Zug, ChMarketing head responsible for commercializing Rx Dermatology products within Galderma portfolio including EpiDuo®, Oracea®, and Soolantra®. Rebuilt marketing team with best-in-class competencies.• Executed Authorized Generic strategy for Oracea franchise resulting in growth of +22% vs plan.• Oversaw highly successful US launch of Epiduo Forte, significantly exceeding launch expectations. -
Executive Director, Global Marketing Team Lead, Xeljanz FranchisePfizer Jul 2013 - Apr 2015New York, New York, UsDeveloped and implemented the global commercialization strategy for Xeljanz® indications including Ulcerative Colitis, Crohn’s Disease, Psoriatic Arthritis, Ankylosing Spondylitis, and Topical Psoriasis.• Developed global franchise brand plan for Xeljanz® lifecycle indications.• Led cross-functional team in developing EU re-submission regulatory strategy following negative opinion.• Chaired Xeljanz® GI Program Team responsible for achieving global regulatory approval, building launchplatform for Ulcerative Colitis indication, and obtaining leadership endorsement for GI indications.• Managed global brand team responsible for all global marketing activities (ie, symposia, ad boards, etc) -
Sr Director, Global Marketing Lead, Enbrel FranchisePfizer Jul 2010 - Jul 2013New York, New York, UsDefined the global strategy for Enbrel®, managed global brand team, chaired asset lifecycle team, and delivered global annual sales of >$8 billion by re-focusing brand on key business drivers.• Secured funding approvals for two large PH IV trials to drive lifecycle growth.• Led organizational change management effort resulting in cost savings of 55% vs prior year.• Developed strategy to differentiate Enbrel® against future biosimilar competitors.• Achieved “Top 25%” status among across all Pfizer managers based on colleague survey.
-
Sr Director, Marketing Team Lead, Us Enbrel FranchisePfizer Jul 2006 - Jul 2010New York, New York, UsSuccessfully led all aspects of brand planning and P&L management for the $3.8 billion Enbrel® Rheumatologyand Dermatology business in the US. Directly managed a team of 8 professionals and oversaw partner alliance.• Recruited and led exceptional HCP & Medical Education marketing team.• Simplified promotional messaging and enhanced communication emphasis of patient support programs improving overall ROI by 26% of marketing programs.• Developed DTC campaign, “Enough is Enough” which aired nationally in 2008-2011 resulting in a positive trend break in new-to-brand Psoriasis patient starts
-
Group Marketing Director, Us Hospital ProductsEndo International Plc 2003 - 2006Malvern, Pa, UsLed the launch of Depodur, a novel post-operative, epidural pain medication. Hired marketing team and built 70 person hospital sales organization. -
Marketing DirectorMerck 1991 - 2003Rahway, New Jersey, UsMultiple roles in sales, corporate finance, market research, pricing, global and US product management. Completed MBA while a sales representative.
Brian Mulnix Skills
Brian Mulnix Education Details
-
University Of Michigan - Stephen M. Ross School Of BusinessFinance -
University Of MinnesotaEconomics
Frequently Asked Questions about Brian Mulnix
What company does Brian Mulnix work for?
Brian Mulnix works for Dr. Reddy's Laboratories
What is Brian Mulnix's role at the current company?
Brian Mulnix's current role is General Manager, Biologics North America.
What is Brian Mulnix's email address?
Brian Mulnix's email address is br****@****rma.com
What is Brian Mulnix's direct phone number?
Brian Mulnix's direct phone number is +121257*****
What schools did Brian Mulnix attend?
Brian Mulnix attended University Of Michigan - Stephen M. Ross School Of Business, University Of Minnesota.
What skills is Brian Mulnix known for?
Brian Mulnix has skills like Pharmaceutical Industry, Product Launch, Rheumatology, Strategy, Biotechnology, Marketing Management, Market Research, Pharmaceutical Sales, Oncology, Cross Functional Team Leadership, Global Marketing, Commercialization.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial